Sun Pharmaceutical Industries Ltd.

The Revenue for the quarter ended  December 2023 of Rs. 50737.50 millions grew by 9.21 % from Rs. 46457.50 millions.A comparatively good net profit growth of 48.20% to Rs. 7213.10 millions was reported for the quarter ended December 2023 compared to Rs. 4867.30 millions of previous same quarter.Operating profit surged to 14358.00 millions from the corresponding previous quarter of 10674.10 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202312	202212	% Var	202312	202212	% Var	202303	202203	% Var
Sales	50737.50	46457.50	9.21	146360.30	148639.20	-1.53	208121.40	155859.80	33.53
Other Income	2284.80	746.30	206.15	5079.50	2925.50	73.63	3292.90	11968.80	-72.49
PBIDT	14358.00	10674.10	34.51	40409.60	42709.40	-5.38	67518.90	38654.40	74.67
Interest	2149.20	1308.90	64.20	5664.90	3107.30	82.31	4721.80	3881.00	21.66
PBDT	11510.70	9365.20	22.91	32554.50	39602.10	-17.80	33419.20	16568.10	101.71
Depreciation	3996.00	4304.40	-7.16	12075.80	11888.90	1.57	16008.70	13499.50	18.59
PBT	7514.70	5060.80	48.49	20478.70	27713.20	-26.10	17410.50	3068.60	467.38
TAX	301.60	193.50	55.87	572.90	597.80	-4.17	503.30	4068.50	-87.63
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	7213.10	4867.30	48.20	19905.80	27115.40	-26.59	16907.20	-999.90	-1790.89
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	28.30	22.98	23.17	27.61	28.73	-3.91	32.44	24.80	30.81